a patient inclusive approach: dr. george demetri | dana-farber cancer institute
Published 12 years ago • 3.3K plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
3:32
dr. george demetri on blood test for cancer mutations | dana-farber cancer institute
-
4:48
dr. george demetri on liposarcoma | dana-farber cancer institute
-
16:17
george demetri, md - oral history | dana-farber cancer institute
-
3:46
what is sarcoma? | dana-farber cancer institute
-
4:38
sarcoma, a glimpse at a rare cancer
-
51:48
world leading geneticist and immunologist josef penninger on potential covid-19 treatment
-
8:16
when to suspect sarcoma
-
0:52
dr. george demetri on being named a giant of cancer care
-
4:10
enrollment and participation in project flag - dana-farber cancer institute
-
1:17
dr. demetri calls for nominations for the 2019 giants of cancer care
-
1:16
working as a group at dana-farber: dr. george canellos | dana-farber cancer institute
-
5:28
project flag: families learning about gist - dana-farber cancer institute
-
1:37
aacr24: rebecca porter, md, endometrial cancer | dana-farber cancer institute
-
2:04
dr. demetri on the evolving field of sarcoma
-
1:23
dr. george demetri discusses regorafenib for patients with gist trial results
-
2:43
george d. demetri, md: clinical trials on soft tissue sarcoma, design and objetives
-
1:29
dr. george demetri on the mutagenic properties and future potentials of dacarbazine
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
11:05
the future is now: george d. demetri, md
-
15:01
2015 bridge project symposium: george demetri
-
1:58
the convergence of targeted therapies and immuno-oncology in sarcoma